Trevi Therapeutics, Inc.

TRVI·NasdaqGM
Compare
12.93−0.26 (−1.97%)today
At close: Oct 12, 4:00 PM EDT · May be delayed up to 15 min · USD
After hours12.930.00 (0.00%)Oct 12, 5:30 PM EDT

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close13.19
Open13.14
Day range12.8113.46
52-week range9.2820.22
Off day high−3.94%
Off 52-week high−36.05%
Volume4.72M
Avg. volume (3M)2.09M
Market cap1.84B
EPS (TTM)-0.3500
Forward P/E-22.41
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)—
Shares outstanding142.48M
Short interest—
Earnings dateAug 6, 2026
Analyst target—
Profit margin—

Against its peers

Compare in full ›
TRVI INVA VCRE INSM BHVN RNTX
Market cap 1.84B 1.55B 259.96M 21.52B 1.78B 67.71M
P/E (TTM) — 5.0 — — — —
Forward P/E -22.4 9.7 — 125.2 -6.3 —
Price/book 5.7 1.3 — 28.4 145.8 6.6
Dividend yield — — — — — —
1-year change +35.84% +25.21% −44.62% −38.64% −29.11% −39.85%
Today −1.97% +1.13% +2.56% −2.03% −2.24% −1.15%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All TRVI news ›

No recent coverage in the 4Search index.

From articles in the 4Search news index.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use.